Significant Ownership of Foundation Fighting Blindness Retinal Degeneration Fund

Signature - Title
/s/ Russell Kelley - Russell Kelley, Managing Director
Location
Raleigh, NC
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Foundation Fighting Blindness Retinal Degeneration Fund.

Notify me when Foundation Fighting Blindness Retinal Degeneration Fund files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Foundation Fighting Blindness Retinal Degeneration Fund

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IRD Opus Genetics, Inc. Common Stock, $0.0001 par value per share 8% $10,819,577 -$7,880,000 5,492,171 -42% Foundation Fighting Blindness Retinal Degeneration Fund 09 Dec 2025

Schedules 13D/G Reported by Foundation Fighting Blindness Retinal Degeneration Fund:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.